David Weiner
Direktor/Vorstandsmitglied bei BRIGHT MINDS BIOSCIENCES INC.
Vermögen: - $ am 30.04.2024
Profil
David M.
Weiner is currently serving as the Co-Chairman at AxoSim, Inc. and as a Non-Executive Director at Bright Minds Biosciences, Inc. He is also the Chief Medical Officer at SwanBio Therapeutics, Inc. Previously, he held positions such as Chief Executive Officer at Amathus Therapeutics, Inc., Senior Medical Director at ACADIA Pharmaceuticals, Inc., Chief Medical Officer at aTyr Pharma, Inc., Faculty Member at the University of California San Diego and the University of Vermont, Vice President & Head-Early Clinical Development at EMD Serono, Inc., Chief Executive & Medical Officer at Proteostasis Therapeutics, Inc., Chief Medical Officer at Lumos Pharma Sub, Inc., and Chief Medical Officer at Chemomab Therapeutics Ltd.
Dr. Weiner completed his undergraduate degree at Brandeis University and obtained his doctorate from UB School of Medicine & Biomedical Sciences.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
05.02.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von David Weiner
Unternehmen | Position | Beginn |
---|---|---|
BRIGHT MINDS BIOSCIENCES INC. | Direktor/Vorstandsmitglied | 17.02.2023 |
AxoSim, Inc.
AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Vorsitzender | 28.02.2024 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von David Weiner
Unternehmen | Position | Ende |
---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Technik-/Wissenschafts-/F&E-Leiter | 14.11.2022 |
ATYR PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 19.07.2015 |
Amathus Therapeutics, Inc.
Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Vorstandsvorsitzender | - |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Technik-/Wissenschafts-/F&E-Leiter | - |
University of Vermont | Corporate Officer/Principal | - |
Ausbildung von David Weiner
Brandeis University | Undergraduate Degree |
UB School of Medicine & Biomedical Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ACADIA PHARMACEUTICALS INC. | Health Technology |
ATYR PHARMA, INC. | Health Technology |
BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Private Unternehmen | 6 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
AxoSim, Inc.
AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Technology Services |
Amathus Therapeutics, Inc.
Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Finance |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |